An amino acid cluster-inspired nanoplatform exhibits LAT1-mediated cell targeting for tumor delivery.
Conventional tumor-targeted nanocarriers remain limited by heterogeneous intratumoral distribution, which arises from abnormal tumor vasculature, dense extracellular matrix barriers, and spatially variable receptor expression. These biological barriers restrict deep tumor penetration and prevent homogeneous nanocarrier...